After-Hours Movers 05/17: (PSUN) (OSIR) (CRM) (BSX) Higher; (SQNM) (ARUN) (SIRI) Lower
Tweet
Share
E-mail
Get Alerts PSUN Hot Sheet
Join SI Premium – FREE
Pacific Sunwear Of California (NASDAQ: PSUN) 22% HIGHER; reported Q1 EPS of ($0.20), $0.09 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $173.8 million versus the consensus estimate of $169.94 million. Pacific Sunwear Of California sees Q2 2012 EPS of $-0.11-$-0.16, versus the consensus of $-0.15.
Osiris Therapeutics Inc. (NASDAQ: OSIR) 14% HIGHER; announced today it has received market authorization from Health Canada to market its stem cell therapy Prochymal® (remestemcel-L), for the treatment of acute graft-vs-host disease (GvHD) in children. The historic decision marks the worldâs first regulatory approval of a manufactured stem cell product and the first therapy approved for GvHD â a devastating complication of bone marrow transplantation that kills up to 80 percent of children affected, many within just weeks of diagnosis.
Sequenom Inc., (Nasdaq: SQNM) 7.2% LOWER; through its wholly owned subsidiary Sequenom Center for Molecular Medicine, LLC, (Sequenom CMM) entered into the recently announced provider network participation agreement with Coventry Health Care National Network, Inc. on May 4, 2012. The agreement included an effective date of July 1, 2012 for Sequenom CMM's participation in provider networks offered and sold by Coventry.
Aruba Networks, Inc. (NASDAQ: ARUN) 5.8% LOWER; reported Q3 EPS of $0.16, in-line with the analyst estimate of $0.16. Revenue for the quarter came in at $131.9 million versus the consensus estimate of $131.7 million.
Salesforce.com, Inc. (NYSE: CRM) 5.6% HIGHER; reported Q1 EPS of $0.37, $0.03 better than the analyst estimate of $0.34. Revenue for the quarter came in at $695 million versus the consensus estimate of $678.15 million. Sees FY2013 revenue of $2.97-$3 billion, versus the consensus of $2.95 billion.
Boston Scientific Corporation (NYSE: BSX) 4.5% HIGHER; announces U.S. Food and Drug Administration approval and market launch of the Epic Vascular Self-Expanding Stent System. The Epic Stent is designed to open blocked arteries in patients with iliac artery stenosis, a form of peripheral vascular disease associated with severe leg pain caused by insufficient blood flow.
Marvell Technology Group Ltd (NASDAQ: MRVL) 4.3% HIGHER; reported Q1 EPS of $0.23, $0.02 better than the analyst estimate of $0.21. Revenue for the quarter came in at $796 million versus the consensus estimate of $767.88 million. The company also initiated a 6 cent per share quarterly dividend and added $500 million to its buyback program. On its Q1 conference call, an exec said the company is looking for quarter-over-quarter sales growth of 6-12 percent.
Kinder Morgan, Inc. (NYSE: KMI) 3.8% HIGHER; will replace El Paso Corp. (NYSE: EP) in the S&P 500 index after the close of trading on Thursday, May 24.
SIRIUS XM Radio Inc. (Nasdaq: SIRI) 1% LOWER; CEO Mel Karmazin disclsoed the sale of 13,700,000 shares from 05/15-05/16 at prices from $1.9768-$1.9865 after exercising options. Karmizin exercised options on the same number of shares at $0.43. The options have an expiration date of 12/31/2014. The transactions were pursuant to the Sales Plan adopted by Mr. Karmazin on February 16, 2012.
Osiris Therapeutics Inc. (NASDAQ: OSIR) 14% HIGHER; announced today it has received market authorization from Health Canada to market its stem cell therapy Prochymal® (remestemcel-L), for the treatment of acute graft-vs-host disease (GvHD) in children. The historic decision marks the worldâs first regulatory approval of a manufactured stem cell product and the first therapy approved for GvHD â a devastating complication of bone marrow transplantation that kills up to 80 percent of children affected, many within just weeks of diagnosis.
Sequenom Inc., (Nasdaq: SQNM) 7.2% LOWER; through its wholly owned subsidiary Sequenom Center for Molecular Medicine, LLC, (Sequenom CMM) entered into the recently announced provider network participation agreement with Coventry Health Care National Network, Inc. on May 4, 2012. The agreement included an effective date of July 1, 2012 for Sequenom CMM's participation in provider networks offered and sold by Coventry.
Aruba Networks, Inc. (NASDAQ: ARUN) 5.8% LOWER; reported Q3 EPS of $0.16, in-line with the analyst estimate of $0.16. Revenue for the quarter came in at $131.9 million versus the consensus estimate of $131.7 million.
Salesforce.com, Inc. (NYSE: CRM) 5.6% HIGHER; reported Q1 EPS of $0.37, $0.03 better than the analyst estimate of $0.34. Revenue for the quarter came in at $695 million versus the consensus estimate of $678.15 million. Sees FY2013 revenue of $2.97-$3 billion, versus the consensus of $2.95 billion.
Boston Scientific Corporation (NYSE: BSX) 4.5% HIGHER; announces U.S. Food and Drug Administration approval and market launch of the Epic Vascular Self-Expanding Stent System. The Epic Stent is designed to open blocked arteries in patients with iliac artery stenosis, a form of peripheral vascular disease associated with severe leg pain caused by insufficient blood flow.
Marvell Technology Group Ltd (NASDAQ: MRVL) 4.3% HIGHER; reported Q1 EPS of $0.23, $0.02 better than the analyst estimate of $0.21. Revenue for the quarter came in at $796 million versus the consensus estimate of $767.88 million. The company also initiated a 6 cent per share quarterly dividend and added $500 million to its buyback program. On its Q1 conference call, an exec said the company is looking for quarter-over-quarter sales growth of 6-12 percent.
Kinder Morgan, Inc. (NYSE: KMI) 3.8% HIGHER; will replace El Paso Corp. (NYSE: EP) in the S&P 500 index after the close of trading on Thursday, May 24.
SIRIUS XM Radio Inc. (Nasdaq: SIRI) 1% LOWER; CEO Mel Karmazin disclsoed the sale of 13,700,000 shares from 05/15-05/16 at prices from $1.9768-$1.9865 after exercising options. Karmizin exercised options on the same number of shares at $0.43. The options have an expiration date of 12/31/2014. The transactions were pursuant to the Sales Plan adopted by Mr. Karmazin on February 16, 2012.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
- Independent Bank (IBCP) Declares $0.24 Quarterly Dividend; 3.9% Yield
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Standard & Poor's, Mel Karmazin, Dividend, After-Hours MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
